Luyan Medicine: Net profit of 281 million yuan in 2025, down 18.74% year-on-year

Luyan Pharmaceutical Announcement, 2025 operating revenue of 21.25B yuan, a year-on-year increase of 3.79%; net profit of 281 million yuan, a year-on-year decrease of 18.74%. Plans to distribute a cash dividend of 3.5 yuan (including tax) for every 10 shares to all shareholders, no bonus shares will be issued, and no capital reserve will be converted into share capital.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin